Clinical aspects of MuSK antibody positive seronegative MG
- PMID: 12821744
- DOI: 10.1212/01.wnl.0000065882.63904.53
Clinical aspects of MuSK antibody positive seronegative MG
Abstract
Serum antibodies to muscle-specific receptor tyrosine kinase were detected in 12 of 32 patients with generalized seronegative MG. All were women, with onset between ages 21 and 59 years. Seven had prominent neck, shoulder, or respiratory muscle weakness and little or delayed ocular muscle involvement. The response to cholinesterase inhibitors was variable, and electromyographic findings suggested myopathy in several. None improved after thymectomy. All patients improved after plasma exchange, and most had a good response to selected immunotherapy. MuSK antibody status should help diagnose MG with atypical presentations and ensure appropriate patient treatment.
Similar articles
-
["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].Med Clin (Barc). 2005 Jun 18;125(3):100-2. doi: 10.1157/13076937. Med Clin (Barc). 2005. PMID: 15989843 Spanish.
-
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.Brain. 2003 Oct;126(Pt 10):2304-11. doi: 10.1093/brain/awg223. Epub 2003 Jun 23. Brain. 2003. PMID: 12821509
-
Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.J Clin Apher. 2015 Oct;30(5):314-9. doi: 10.1002/jca.21377. Epub 2014 Dec 30. J Clin Apher. 2015. PMID: 25557356
-
[Seronegative myasthenia gravis].Rev Neurol (Paris). 2004 Feb;160(2):159-62. doi: 10.1016/s0035-3787(04)70886-3. Rev Neurol (Paris). 2004. PMID: 15034472 Review. French.
-
Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004. Neurol Clin. 2018. PMID: 29655451 Free PMC article. Review.
Cited by
-
Myasthenia gravis.Orphanet J Rare Dis. 2007 Nov 6;2:44. doi: 10.1186/1750-1172-2-44. Orphanet J Rare Dis. 2007. PMID: 17986328 Free PMC article. Review.
-
Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China.Front Neurol. 2022 Apr 8;13:879261. doi: 10.3389/fneur.2022.879261. eCollection 2022. Front Neurol. 2022. PMID: 35463138 Free PMC article.
-
Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation.Curr Treat Options Neurol. 2005 Jan;7(1):3-14. doi: 10.1007/s11940-005-0001-7. Curr Treat Options Neurol. 2005. PMID: 15610702
-
Myasthenia Gravis: Do the Subtypes Matter?Ann Indian Acad Neurol. 2020 Jan-Feb;23(1):2. doi: 10.4103/aian.AIAN_595_19. Epub 2020 Jan 21. Ann Indian Acad Neurol. 2020. PMID: 32055109 Free PMC article. No abstract available.
-
Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis.PLoS One. 2014 Dec 1;9(12):e110571. doi: 10.1371/journal.pone.0110571. eCollection 2014. PLoS One. 2014. PMID: 25438154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical